Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema

Expert Review of Medical Devices

Volumn 9, Issue 2, 2012, Pages 189-197

  Sivaprasad, Sobha ^a   Dorin, Giorgio ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b IRIDEX Corporation   (United States)

Author keywords

diabetic retinopathy; diode laser; macular edema; micropulse; photocoagulation; subthreshold

Indexed keywords

DIABETIC RETINOPATHY; MACULAR EDEMA; MICROPULSE; PHOTOCOAGULATION; SUBTHRESHOLD;

EYE PROTECTION; TISSUE;

SEMICONDUCTOR LASERS;

PEGAPTANIB; RANIBIZUMAB;

FUNCTIONAL ASSESSMENT; HUMAN; LASER COAGULATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA EDEMA; REVIEW; RISK ASSESSMENT; SUBTHRESHOLD DIODE LASER MICROPULSE PHOTOCOAGULATION; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

CLINICAL TRIALS AS TOPIC; DIABETIC RETINOPATHY; HUMANS; LASERS, SEMICONDUCTOR; LIGHT COAGULATION; MACULAR EDEMA; TREATMENT OUTCOME;

EID: 84858216312     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.12.1     Document Type: Review

References (58)

1. Writing Committee for the Diabetic Retinopathy Clinical Research Network. Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch. Ophthalmol. 125, 469-480 (2007
2. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch. Ophthalmol. 103, 1796-1806 (1985
3. The Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study report no. 3. Int. Ophthalmol. Clin. 27, 254-264 (1987
4. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology 98, S766-S785 (1991
5. Striph GG, Hart WM Jr, Olk RJ. Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visual field. Ophthalmology 95, 1673-1679 (1988 (Pubitemid 19000630)
6. Hudson C, Flanagan JG, Turner GS, et al. Influence of laser photocoagulation for clinically significant diabetic macular edema (DMO) on short-wavelength and conventional automated perimetry. Diabetologia 41, 1283-1292 (1998 (Pubitemid 28488754)
7. Sinclair SH, Alaniz R, Presti P. Laser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing. Sem. Ophthalmol. 4, 214-222 (1999 (Pubitemid 30061164)
8. Schatz H, Madeira D, McDonald HR, et al. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch. Ophthalmol. 109, 1549-1551 (1991
9. Lewis H, Schachat AP, Haimann MH, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 97, 503-510 (1990
10. Guyer DR, DAmico DJ, Smith CW. Subretinal fibrosis after laser photocoagulation for diabetic macular edema. Am. J. Ophthalmol. 113, 652-656 (1992
11. Han DP, Mieler WF, Burton TC. Submacular fibrosis after photocoagulation for diabetic macular edema. Am. J. Ophthalmol. 113, 513-521 (1992
12. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology 104(12), 2030-2038 (1997 (Pubitemid 28053429)
13. Moorman CM, Hamilton AMP. Clinical applications of the MicroPulse diode laser. Eye 13(Pt 2), 145-150 (1999 (Pubitemid 29210130)
14. Stanga PE, Reck AC, Hamilton AMP. Micropulse laser in the treatment of diabetic macular edema. Semin. Ophthalmol. 14(4), 210-213 (1999 (Pubitemid 30061163)
15. Friberg TR. Infrared micropulsed laser treatment for diabetic macular edema -subthreshold versus threshold lesions. Semin. Ophthalmol. 16(1), 19-24 (2001 (Pubitemid 34132528)
16. Olk RJ, Akduman L. Minimal intensity diode laser photocoagulation (MIP) for diffuse DME. Semin. Ophthalmol. 16(1), 25-30 (2001
17. Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br. J. Ophthalmol. 88(9), 1173-1179 (2004 (Pubitemid 39141379)
18. Tseng Shih-Yu. Clinical application of micropulse diode laser in the treatment of macular edema. Am. J. Ophthalmol. 139(4), S58 (2005
19. Bhagat N, Zarbin MA. Use of diode subthreshold micropulse laser for treating diabetic macular edema. Contemp. Ophthalmol. 3(13), 1-10 (2004
20. Bhagat N, Zarbin MA. Diode subthreshold micropulse laser for diabetic macular edema. Retinal Physician 3(2), 53-56 (2006
21. Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br. J. Ophthalmol. 89(1), 74-80 (2005 (Pubitemid 40040243)
22. Luttrull JK. Atraumatic photocoagulation for retinovascular disease. Retinal Physician 3(2), 65-69 (2006
23. Luttrull JK, Spink CJ. Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surg. Lasers Imaging 37(5), 370-377 (2006 (Pubitemid 44519241)
24. Dare A, Castro L, Lavinsky D, Navajas E, Cardillo JA. Novos horizontes no tratamento do edema de macula diabetico: fotocoagulacao macular seletiva com micropulse de diodo 810 nm. JBO 13, 16-20 (2007
25. Sivaprasad S, Sandhu R, Tandon A, Sayed-Ahmed K, McHugh DA. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up. Clin. Experiment. Ophthalmol. 35(7), 640-644 (2007 (Pubitemid 47491221)
26. Fletcher E, Chong V. Diabetic macular oedema -is micropulse laser treatment the way forward? Ophthalmol. Int. 3(1), 19-22 (2008
27. Nakamura Y, Tatsumi T, Arai M, Takatsuna Y, Mitamura Y, Yamamoto S. [Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates]. Nippon Ganka Gakkai Zasshi 113(8), 787-791 (2009
28. Figueira J, Khan J, Nunes S, et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br. J. Ophthalmol. 93(10), 1341-1344 (2009
29. Ohkoshi K, Yamaguchi T. Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients. Am. J. Ophthalmol. 149(1), 133-139 (2010
30. Nakamura Y, Mitamura Y, Ogata K, Arai M, Takatsuna Y, Yamamoto S. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema. Eye (Lond.) 24(5), 784-788 (2010
31. Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30(6), 908-916 (2010
32. Kumar V, Ghosh B, Mehta DK, Goel N. Functional outcome of subthreshold versus threshold diode laser photocoagulation in diabetic macular oedema. Eye (Lond.) 24(9), 1459-1465 (2010
33. Lavinsky D, Cardillo JA, Melo LA Jr, Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest. Ophthalmol. Vis. Sci. 52, 4314-4323 (2011
34. Venkatesh P, Ramanjulu R, Azad R, Vohra R, Garg S. Subthreshold micropulse diode laser anddouble frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed. Laser Surg. 29(11), 727-733 (2011
35. Takatsuna Y, Yamamoto S, Nakamura Y, Tatsumi T, Arai M, Mitamura Y. Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema. Jpn J. Ophthalmol. 55(4), 365-369 (2011
36. Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Long-term safety, high-resolution imaging, and tissue temperature modeling of sub-visible diode micropulse photocoagulation for retinovascular macular edema. Retina 32(2), 375-386 (2012
37. Shah AM, Bressler NM, Jampol LM. Does laser still have a role in the management of retinal vascular and neovascular diseases? Am. J. Ophthalmol. 152(3), 332-339.e1 (2011
38. Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin. Ophthalmol. 14(4), 200-209 (1999 (Pubitemid 30061162)
39. Lanzetta P, Dorin G, Piracchio A, Bandello F. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin. Ophthalmol. 16(1), 8-11 (2001 (Pubitemid 34132526)
40. Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin. Ophthalmol. 18(3), 147-153 (2003 (Pubitemid 38404840)
41. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it? Semin. Ophthalmol. 19(1-2), 62-68 (2004 (Pubitemid 39658411)
42. Sivaprasad S, Elagouz M, McHugh D, Shona O, Dorin G. Micropulsed diode laser therapy: evolution and clinical applications. Surv. Ophthalmol. 55, 516-530 (2010
43. Wilson AS, Hobbs BG, Shen WY, et al. Argon laser photocoagulation-induced modification of gene expression in the retina. Invest. Ophthalmol. Vis. Sci. 44, 1426-1434 (2003 (Pubitemid 36378564)
44. Faxel C, Bradle J, Acott T, Samples JR. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 27, 629-634 (2007 (Pubitemid 46905156)
45. Battaglia Parodi M, Spasse S, Iacono P, et al. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 113, 2237-2242 (2006 (Pubitemid 44838903)
46. Parodi MB, Iacono P, Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular edema in branch retinal vein occlusion: a pilot study. Br. J. Ophthalmol. 92, 1046-1050 (2008
47. Ricci F, Missiroli F, Cerulli L. Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy. Eur. J. Ophthalmol. 14(1), 74-82 (2004 (Pubitemid 38352186)
48. Lanzetta P, Furlan F, Morgante L, Verritti D, Bandello F. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur. J. Ophthalmol. 18(6), 934-940 (2008
49. Chen SN, Hwang JF, Tseng LF, Lin CJ. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 115(12), 2229-2234 (2008
50. Ricci F, Missiroli F, Regine F, Grossi M, Dorin G. Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 247(5), 597-607 (2009
51. Luttrull JK, Musch DC, Spink CA. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy. Eye (Lond.) 22, 607-612 (2008 (Pubitemid 351712354)
52. Kumar V, Ghosh B, Raina UK, Goel N. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy, Eye (Lond.) 23(11), 2122-2123 (2009
53. Luttrull JK, Musch DC, Spink CA. Reply to Dr Kumar, et al. Eye (Lond.) 23(11), 2123 (2009
54. JA Cardillo. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Presented at: Annual Meeting of the Retina Society. Scottsdale, AZ, USA, 25-28 September, 2008
55. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study. Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118, 615-625 (2011
56. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study). A 12-month, randomized, controlled, double-masked, multicenter Phase II study. Diabetes Care 33, 2399-2405 (2010
57. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) Study. Ophthalmology 117, 2146-2151 (2010
58. Sultan MB, Zhou D, Loftus J, et al. A Phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology 118, 1107-1118 (2011